Denosumab Solution For Injection

Get a Price/Quote

MOQ : 50 Vials

Denosumab Solution For Injection Specification

Origin of Medicine
India

Life Span
24 months from the manufacturing date

Brand Name
Denosumab

Indication
Osteoporosis in postmenopausal women and men at increased risk of fracture; bone loss due to hormone ablation in cancer; prevention of skeletal-related events in cancer

Pacakaging (Quantity Per Box)
1 Syringe/Box

Dosage Form
Injection

Salt Composition
Denosumab

Packaging Type
Pre-filled Syringe

Drug Type
Biological

Ingredients
Denosumab

Physical Form
Solution

Function
Prevention of bone fracture and bone loss

Recommended For
Treatment of osteoporosis, bone loss, and certain cancers affecting bones

Dosage
As directed by physician, commonly 60 mg subcutaneously every 6 months

Dosage Guidelines
For subcutaneous use only. Administer as prescribed by healthcare professional.

Suitable For
Adults

Quantity
1 Pre-filled Syringe

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze. Protect from light.

Appearance
Clear to slightly opalescent, colorless to pale yellow solution

Strength
60 mg/ml

Use in Pregnancy & Lactation
Not recommended unless clearly needed and prescribed by a physician

LATEX Content
Latex-free syringe

Route of Administration
Subcutaneous

Caution
Should not be used in patients with hypocalcemia; correct calcium levels before treatment

Marketed By
Certified pharmaceutical distributor

Prescription Required
Yes

Denosumab Solution For Injection Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Vials Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Denosumab Solution For Injection

Spotlight your bone health with Denosumab Solution For Injection, an elite, latex-free therapy uniquely designed to command the prevention of bone loss and fractures. Utilise this offer, highlighted by a champion formulation of 60 mg/ml Denosumab, administered subcutaneously for enhanced effectiveness. With a clear to slightly opalescent appearance, each pre-filled syringe ensures precision and safety, suitable for adults and expertly championed for osteoporosis or cancer-related bone concerns. Prescription required. Store refrigerated. Shine in the fight against skeletal challenges and maintain robust bone integrity with Denosumab - your commanding solution.

Elite Surface and Area of Application of Denosumab Injection

Denosumab Solution For Injection is expertly highlighted for subcutaneous use, directly targeting the underlying bone tissue. The solution is injected into the fatty layer beneath the skin, making it suitable for a broad range of areas on the body, as advised by a physician. This product is designed for use by adults, both male and female, facing osteoporosis or bone loss challenges, ensuring focused, elite care at the point of need.

Valuation and Logistics of Denosumab Packaging and Distribution

Each Denosumab Solution For Injection is valuated for quality and securely shipped as a single pre-filled syringe per box. The logistics are championed for timely delivery across the main domestic market, India, ensuring product integrity throughout the cold chain. Payment terms are flexible to meet varied procurement needs, spotlighting a seamless experience from purchase to administration while maintaining high standards in safety and distribution.

FAQ's of Denosumab Solution For Injection:

Q: How should Denosumab Solution For Injection be administered?

A: Denosumab Solution For Injection is administered subcutaneously, meaning it is injected into the fatty tissue just beneath the skin. It should be given by a healthcare professional, following the prescribed dosage, typically 60 mg every six months.

Q: What are the benefits of using Denosumab for osteoporosis?

A: Denosumab helps reduce bone loss and lowers the risk of fractures in adults suffering from osteoporosis or those with bone loss due to cancer treatments. It provides elite protection and support in strengthening bone structure.

Q: What precautions are necessary before starting Denosumab treatment?

A: Patients must have normal or corrected calcium levels before receiving Denosumab, as it is not recommended in cases of hypocalcemia. It is vital to consult a physician for appropriate evaluations and instructions.

Q: When is Denosumab not recommended for use?

A: Denosumab should not be used in pregnant or lactating women unless prescribed by a healthcare professional. It is also not suitable for individuals with untreated low calcium levels.

Q: Where should Denosumab Solution For Injection be stored before use?

A: This medication must be stored in a refrigerator between 2C and 8C. It should not be frozen and must be protected from light to maintain its efficacy.

Q: What is the process for administering Denosumab Solution?

A: The injection process involves selecting an appropriate subcutaneous site, as guided by a healthcare provider, and administering the medication using the pre-filled syringe supplied. Dosage and frequency are determined by a physician based on individual needs.

Tell us about your requirement